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Cost-effectiveness and value of information
analysis of a low-friction environment
following skin graft in patients with burn
injury
Rebecca Kandiyali1* , Howard Thom1, Amber E. Young1,2, Rosemary Greenwood2 and Nicky J. Welton1
Abstract
Background: Patients with burn injuries may receive a skin graft to achieve healing in a timely manner. However, in
around 7% of cases, the skin graft is lost (fails to attach to the wound site) and a re-grafting procedure is necessary. It has
been hypothesised that low-friction (smooth, more slippery) bedding may reduce the risk of skin-graft loss. A before and
after feasibility study comparing low-friction with standard bedding in skin-grafted patients was conducted in order to
collect proof of concept data. The resulting relative risk on the primary outcome (number of patients with skin graft failure)
for the non-randomised study provided no evidence of effect but had a large standard error. The aim of this study is to see
if an appropriately powered randomised control trial would be worthwhile.
Methods: A probabilistic decision-analytic model was constructed to compare low-friction bedding to standard care in a
population of burn patients who have undergone skin grafting. Results from the before and after study were used as model
inputs. The sensitivity of results to bias in the relative risk of graft loss was conducted. Low-friction bedding is considered
optimal if expected incremental net benefit (INB) is positive. Uncertainty is assessed using cost-effectiveness acceptability
curves. Expected Value of Perfect Partial Information (EVPPI) provides an upper bound for the potential net health benefits of
new research for given model input.
Results: At a willingness to pay threshold of £20,000 per QALY, INB = £151 (95% Credible Interval (CrI) −142 to 814),
marginally favouring low-friction bedding but with high uncertainty (probability of being cost-effective 70.5%).
Expected value of perfect information (EVPI) per patient was £20.29, which results in a population EVPI of £174,765 over
a 10-year lifetime for the technology (based on 1000 patients per year who would benefit from the intervention). The
parameter contributing most to the uncertainty was the inpatient care cost, i.e. information that could be obtained
from the audit of practice and without an expensive trial. These findings were robust to a wide-range of assumptions
about the potential bias due to the observational nature of the comparative evidence.
Conclusions: Our study results suggest that an RCT (randomised controlled trial) is unlikely to be worthwhile, but there
may be value in a study to estimate the re-graft rates and associated costs in this population.
Keywords: Cost-effectiveness analysis, Proof of concept study, Randomised controlled trial, Value of information analysis
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Background
A burn injury to the skin or other tissue occurs when
cells are destroyed by hot liquids (scalds), hot solids,
flames, electricity, chemicals or cold [1]. Around 130,
000 patients with burns present to English and Welsh
hospitals annually; 45,000 are severe enough to re-
quire hospital follow-up [1]. Of these, 11,500 patients
require admission of which 50% are children [2]. Glo-
bally, 11 million people are estimated to suffer burns
significant enough to warrant medical attention [3].
Early wound closure after an injury is the aim of all
modern burn care pathways resulting in improvement
in survival at a substantially lower cost, better cos-
metic outcomes and shorter lengths of hospital stay
[4]. Skin grafts are used to treat burns to achieve
healing in full-thickness burns (where the three layers
of skin known as the epidermis, dermis and subcutis
are damaged) or for the best cosmetic outcome in
partial-thickness burns (where the top two layers, i.e.
the epidermis and dermis are damaged) failing to heal
within 3 weeks [5]. There are roughly 1000 skin grafts
undertaken to achieve healing annually at burns ser-
vices nationally; 75% in adults and 25% in children
[2]. National Burns Injury database (iBID) data sug-
gest that 20 to 30% of patients will require further
grafting procedures. Some of this graft failure will be
due to infection and some due to friction when the
graft rubs against other materials (graft loss because
of friction between bedsheets and another material,
such as a bedsheet). It is difficult to determine how
many of graft failures are due to friction alone.
Wounds that fail to heal will cause considerable dis-
tress to patients, impacting negatively on physical, so-
cial, emotional and economic aspects of their life [6].
Graft loss will result in delayed wound healing, in-
creased hospital stay, repeat surgery, further donor
sites, increased pain and the potential for infection
and increased scar formation; impacting negatively on
UK National Health Service (NHS) costs.
Low-friction bedding has been shown to be a clin-
ical and cost-effective option in the prevention of skin
breakdown in a non-burns population at-risk of skin
breakdown [7]. Therefore, a hypothesis is that low-
friction bedding may reduce the risk of skin-graft loss
in patients with burn injury; however, the data is
presently limited to non-randomised evidence from a
before and after study design [8]. In brief, the Skin
grafting Low friKtion Environment (SILKIE) study
was a non-randomised two-centre study of the feasi-
bility of delivering the low-friction environment with
proof of concept through the comparison of retro-
spective with prospective data collection over 12
months. Given the low level of evidence, there re-
mains uncertainty whether low-friction bedding
prevents skin graft losses. Although low-friction bed-
ding costs more than standard bedding, if it reduces
graft loss, then this is expected to make a saving to
the NHS, since re-grafting is expensive (due to the
cost of the re-graft procedure and associated in-
patient stay). We are therefore uncertain about both
effectiveness and cost-effectiveness. This raises the
question as to whether a RCT would be a worthwhile
investment.
The aim of this paper is to build an economic model to as-
sess the cost-effectiveness of low-friction bedding and use this
to (i) assess uncertainty in optimal bedding given current evi-
dence and (ii) to quantify the value of conducting a new RCT
to reduce uncertainty as to the most cost-effective bedding.
The paper is organised as follows. We begin by de-
scribing the decision question and model structure.
We then describe the evidence sources used to popu-
late the model. We then present results from the
cost-effectiveness analysis and value of information
analysis. We finish with a discussion of the implica-
tion of the results for future research priorities.
Methods
The economic model was designed to assess cost-
effectiveness for the following population and interventions.
Population
Patients (adults and children) with burns who have
undergone a skin graft.
Intervention and comparator
The intervention was the use of low-friction bedding in
patients who are recovering from skin graft surgery. The
comparator was standard bedding.
Outcomes
We calculated the Expected net benefit (ENB) and
the probability of being cost-effective. ENB puts costs
and QALYs onto a monetary scale using the formula:
Expected Net Benefit =Expected (QALYs) * lambda
+Expected (costs), where lambda represents the ceil-
ing ratio that society is willing to pay for a gain in
QALY—typically £20,000 in recommendations pre-
sided over by NICE [9]. The Expected Incremental
Net Benefit is the difference between ENB on low-
friction and standard bedding, with positive values in-
dicating that low-friction is optimal. Uncertainty in
the optimal bedding is assessed by reporting credible
intervals around the ENB, and also by constructing
cost-effectiveness acceptability curves (CEACS) to
examine the probability that the intervention is cost-
effective at different levels of willingness to pay
(lambda). We additionally considered the expected
value of perfect information (EVPI)—the expected
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value of eliminating uncertainty on all parameters—
and the expected value of partial perfect information
(EVPPI)—the expected value of eliminating uncer-
tainty on individual parameters. Population EVPI and
EVPPI were determined by estimating the number of
patients who will benefit from the technology over its
lifetime.
Time horizon and discounting
Our base case model has a 28-day time horizon, in-
formed by our clinical experts. The intervention is
primarily a change to the inpatient environment and
the relevant costs and outcomes relate to the period
of skin graft ‘take’, so relative differences in costs and
effects relating to the intervention are likely to occur
in the short term, while the patient is hospitalised.
This is in line with a previous model in a less severe
burns population which had a 21-day time horizon
justified on the basis of time to skin re-epithelisation
and typical inpatient duration [10]. No discounting
was applied to costs and benefits in the model due to
the short time horizon being modelled. However, in
the Population EVPI and EVPPI calculations over a
10-year lifetime horizon of the technology, an annual
discount rate of 3.5% was applied [11].
Model structure
A simple probabilistic decision tree model was con-
structed with input from the clinical team at a ter-
tiary burns service in Bristol, UK. In the specification
of the model, patients are placed on either “Silkie”
[low -friction] or standard bedding after skin graft
surgery. Patients may then lose all or a sufficient
proportion of their grafts such that they require a re-
graft; otherwise, they were not re-grafted. Figure 1 de-
scribes the structure of the 28-day decision-tree
which corresponds to the decision problem which
could be addressed by a full RCT.
Model inputs
Data sources used to populate the model are described
in the following sections. Input parameter values and
distributions used in the probabilistic sensitivity analysis
are presented in Table 1.
Fig. 1 Model diagram. The decision node (square box) shows the
option available to nurses: either to manage patients recovering
from skin graft surgery on standard hospital bedding, or else place
patients on low-friction ‘Silkie’ sheets. The probabilities of
subsequent graft losses (%) emanate from the circular chance nodes.
Expected payoffs (costs and QALYs) to the patient are in turn
weighted by the probabilities




Relative risk (regraft) [low-friction vs.
standard]
0.574 (0.52, 0.63) Lognormal (− 0.56,
0.61)
221 Before and after comparison—Silkie feasibility
study
P (regraft) low-friction 0.038 (0.013, 0.077) Beta (4.96,125.04) 90 Prospective data collection—Silkie feasibility
study
Intervention cost, £ 115 Deterministic 131 Estimate based on unit costing approach
Cost (re-graft), £ 19,321 (9092, 36,251) Lognormal (9.81,
0.35)
131 “”
Cost (no regraft), £ 9908 (8319, 11,705) Lognormal (9.20,
0.09))
131 “”
Utility post surgery 0.353 (0.0056, 0.91) Beta (0.77,1.41) 40 Prospective data collection—Silkie feasibility
study
Utility no graft loss 0.508 (0.11, 0.90) Beta (2.26, 2.19) 27 Prospective data collection—Silkie feasibility
study
Utility graft loss 0.627 (0.57, 0.68) Beta (179.95, 106.82) 2
Discount rate 0.035 (−) Deterministic n/a NICE methods of technology appraisal (2013)
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Relative risk of the low-friction environment (versus
standard care)
Ideally, evidence on relative risks of re-graft would come
from an RCT [12]. In the absence of this, comparative
evidence from the Silkie before and after study was used.
The need for re-grafting on low-friction bedding was a
prospectively collected study outcome and the relative
risk of low-friction versus standard was informed by the
before and after comparison. Because the lack of con-
cealed randomisation can lead to problems of compar-
ability because of selection biases and potential
confounders [13, 14] and because before/after designs
are by definition prone to history bias [15], we per-
formed multiple sensitivity analyses to assumptions on
the magnitude and precision of the bias (see ‘Sensitivity
analyses’).
Absolute risk of graft loss associated with standard care
Absolute risk on standard sheets should come from
representative contemporary practise. The Silkie
study’s before element was informed by retrospective
notes review of graft losses and this informed the ab-
solute and therefore the relative risk used in the
model (as described above).
Cost of re-grafting
Ideally, the cost of re-grafting would come from micro-
costing studies since such studies offer the most compre-
hensive and rigorous methods to capture the cost associ-
ated with a specific procedure [16]. In the absence of this,
we sought to use national reference costs which provide a
source of unit costs based on trust activity [17]. In our
analysis of inpatient costs, we multiplied the cost of an
NHS reference cost ‘inlier’ bed-day by length of stay to
estimate inpatient care costs at the level of the patient.
Bed-day costs were determined by application of the ap-
propriate reference cost category for the procedure(s). In
the absence of more detailed evidence, the cost of re-
grafting was taken to be the incremental difference in the
costs in patients who required re-grafting and those that
did not, based on all patients (i.e. standard care and inter-
vention arms) in the Silkie study.
QALYs
Ideally, data on utilities would be routinely collected
in the population with burn injury to allow for
service evaluation and monitoring. A population-
level sample would greatly increase the precision
around the estimate of expected QALYs. However,
measurement of health-related QoL is not routine in
the UK burn populations, so the utility estimates for
patients who did and did not undergo re-graft sur-
geries were identified from the perspective (interven-
tion arm) of Silkie study. In the first year of the
model, utilities were obtained from EQ-5D utility
scores recorded at baseline and 28 days follow-up
(the latter stratified according to re-graft status) in
the intervention arm in study participants who con-
sented to complete questionnaires.
Analysis
The analysis was performed from the UK NHS
healthcare perspective, and costs were reported in £
for the 2016 price year. We used a Monte Carlo
simulation with 50,000 samples to propagate the joint
uncertainty in model inputs into Net Benefit. In order
to calculate the population level expected value of
perfect information, we considered the technology
relevance horizon for a technology such as this to be
around 10 years. Given an estimated 1000 skin grafts
per annum being carried out in England and Wales
[2], expressing this in present value terms via applica-
tion of a discount rate of 3.5% the expected dis-
counted population over 10 years was 8608. We
additionally calculated the EVPPI using generalised
additive regression (GAM) and integrated nested
Laplace approximation (INLA) using, due to higher
computational demands of GAM and INLA, 10,000 of
the Monte Carlo samples [18, 19].
Sensitivity analyses
As the Silkie study used non-contemporaneous con-
trols, it is likely the estimated relative risk and its
confidence interval may be subject to bias; however,
we do not know the extent of this bias. We explored
the robustness of our conclusions to potential bias by
presenting results for the mean bias (none, favour
Silkie, favour standard), together with inflation or de-
flation of uncertainty (see Table 3). Details of distri-
bution used for the relative risk of bias term are
provided in Table 3.
Table 2 Costs and outcomes of providing the low-friction environment and standard care (28 days)
Intervention Standard Low-friction Incremental
Mean 28-day QALYs 0.033 (0.011, 0.060) 0.0332 (0.010, 0.060) −0.00013 (−0.00073, 0.00034)
Mean 28-day costs (£) 10,536 (8786, 12,689) 10,382 (8748, 12,261) − 154 (− 818, 139)
Expected net benefit at £ 20,000 per QALY − 9870 (−12,072, − 8041) − 9718 (−11,657, − 7999) 151 (−142, 814)
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Model validation
The model was developed in R with the Bayesian Cost-
Effectiveness Analysis package [20, 21]. Face validity of the
model (and particularly the modelled assumptions) was
established through discussion with the Silkie study
management group and, health economic modellers.
Internal validity was systematically checked by asses-
sing the core calculations of the model and applying
a series of logical checks to ensure that the direction
of the model’s predictions were consistent. We add-
itionally used Excel to validate our calculations with
respect to Net Benefit and EVPI. External and cross
validity was more difficult to establish, as there were
no cost-utility or value of information studies in the
target population with which to compare our results.
Reporting
We used the CHEERS reporting guidelines for Economic
Evaluation [22].
Results
Table 2 presents the results from the probabilistic
model over 28 days for the low-friction and stand-
ard bedding. The probabilistic analyses incorporate
the uncertainty around the point estimates of input
parameters (Fig. 2). In the base-case, where the
Silkie study results are taken at face value, the ex-
pected Incremental Net Benefit was £151 in favour
of low-friction bedding at a threshold of £20,000
per QALY gained. However, there was considerable
uncertainty around this estimate (95%CrI £-142 to
814) suggesting that there is no clear optimal strat-
egy based on ENB. Figure 3 presents the cost-
effectiveness acceptability curves which shows that
low-friction bedding has a 70.5% chance of being
cost-effective at a threshold of £20,000 per QALY
gained. Table 3 shows the Population EVPI over the
28-day time horizon is £20.29 per person at a
threshold value of £20,000. For a decision relevance
horizon of 10 years, this corresponds to an overall
expected value of removing decision uncertainty for
England and Wales of £174,675.
Figure 4 describes the EVPPI for individual pa-
rameters. This shows that the parameters causing
most of the decision uncertainty are around costs
and the absolute probability for re-grafting surgery,
regardless of the sheeting environment. Table 3 also
shows the results of the sensitivity analysis for bias
in the relative risk, and implications in terms of ex-
pected net-benefit, the probability that low-friction
is most cost-effective, EVPI and EVPPI parameters.
Fig. 3 Cost-effectiveness acceptability curve
Fig. 4 Expected value of perfect information in
individual parameters
Fig. 2 Scatterplot of cost and effect pairs for low-friction bedding
compared to standard care (28 days)
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EVPPI for further parameter sets under bias scenar-
ios is provided in the Appendix. The probability
that low-friction is most cost-effective is higher
when bias is upwards (favouring low-friction) and
when bias is least uncertain. We see that the EVPI
is greatest when the benefit of low-friction vs
standard is most uncertain (bias against low-friction
bedding with high uncertainty, scenario 4) and low-
est when the benefit is most certain (bias in favour
of low-friction and low uncertainty, scenario 6).
The parameters with largest EVPPI, and with EVPPI
that changes most under bias scenarios, are the
probability of re-graft, relative risk of re-graft, and
the cost of re-graft; utilities appear to have little in-
fluence on decision making and are unaffected by
assumptions about bias in the relative risk (see Ap-
pendix). The final column represents the value of
an RCT exploring the relative risk, with no value in
the base case but the highest value if we assume
the observational evidence is biased against low-
friction bedding and highly uncertain (scenario 4)
or unbiased but highly uncertain (scenario 2). Re-
gardless of the assumptions about bias, there does
not seem to be value in an RCT of low-friction vs
standard bedding. However, there may be value in
conducting another type of study to collect re-graft
costs as population EVPPI for this parameter was
£138,216. This would be much cheaper and prob-
ably worthwhile (given the data would be relevant
for other decision questions for such patients in the
future).
Discussion
This paper reports on the construction of a model to
evaluate the cost-effectiveness of a low-friction envir-
onment in patients who have had recent skin graft
surgery, and the potential value of future research.
Our results suggest that there is no value in a future
RCT regardless of how large we believe the bias from
the before-after Silkie study to be because the cost of
an RCT would far outweigh the benefits from it as
measured by EVPPI. However, we cannot be sure
which is the optimal treatment. This suggests that the
consequences of using low-friction or standard bed-
ding are not sufficiently high for us to be concerned if
the wrong choice is made. However, we found that
there may be value in studies collecting data on the
cost of re-graft surgery and the absolute probability of
re-graft (regardless of bedding type). These data could
be used to update the model and revisit the decision
on bedding, and also would be valuable to inform de-
cisions on other interventions for this population in
the future.
Summary of findings elsewhere
We found no published evaluations in burn manage-
ment using cost-effectiveness modelling. Brown, David
et al. [23] published an economic evaluation of a
distraction-based intervention ‘Ditto’ in paediatric burn
care in Brisbane, Australia based on a small trial (n =
75). The study reported a 95% probability that it was
cost-effective compared with standard care, but the re-
sults are not easily comparable since they report cost
(AU$) per 1-day reduction in re-epithelialization. Else-
where, Tuffaha et al. identify the EVPI for the decision
to adopt negative pressure wound therapy at AUD 2.7
million, which places a much greater value on more re-
search than for our study [24]. We found evidence of an
unpublished UK economic evaluation for a spray-on skin
system in patients with burn injury [10] but the model
developed was only applicable to patients with partial
burns that do not require re-grafting due to a lack of
evidence in grafted patients and did not consider value
of information. Additionally, we are aware of modest lit-
erature on the costs associated with burn injury in child
and adult populations. However, these studies are typic-
ally either very small or report costs based on different
healthcare systems so may not be generalisable [25–30].
Limitations
One limitation is that we present modelled results draw-
ing on a retrospective comparison of patients nursed on
standard bedding, in a preceding 12-month period in the
same hospitals. This lack of a contemporaneous and pro-
spectively collected comparison group is a key limitation
of inference on the basis of feasibility study results. While
we explored these in scenario analyses the nature of bias
(some which may be unobservable) is that we do not
know if the analyses we conducted are reasonable and ex-
plored the full range of possibilities.
We note that the short-time horizon of this model made
it unlikely that we would identify differences in QALYs,
and this may mean that we did not consider the inclusion
of potentially relevant effects. These effects could be sub-
stantial if repeat skin grafts cause long-term or permanent
scarring and the utility decrement (and the associated loss
in QALYs) can be quantified. Further work could set out
to collect data on utilities or elicit informative priors to
describe uncertainty in these parameters [31] in order to
populate a long-term model. Any future model develop-
ment should foreseeably involve patients and the public to
validate such long-term assumptions.
Conclusion
Our model for the UK population suggests that a further
definitive trial is not worthwhile and instead low-cost re-
search audits should focus on the re-graft rates and cost
of graft surgeries.
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